i-Build-a-Case: Diagnosing Postpartum Acquired Hemophilia in Hospitalized Patients
Hematology-Oncology
Credits:
0.7 ANCC Contact Hours 0.75 AMA PRA Category 1 Credit(s) ™
0.7 ANCC Contact Hours 0.75 AMA PRA Category 1 Credit(s) ™
Launch Date:
January 15, 2014
January 15, 2014
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Hematologists, Hematologist/Oncologists, Pediatric Hematologist/Oncologists, Pediatric Hematologists, Surgeons, Anesthesiologists, Intensivists, Critical Care Medicine Specialists, Emergency Medicine Clinicians, Primary Care Physicians, Registered Nurses
Relevant Terms:
Postpartum, Acquired Hemophilia, Rare Bleeding Disorders
| 1. | Identify the clinical presentation and laboratory results to appropriately diagnose postpartum acquired hemophilia (PPAH) | 2. | Explain the significance of inhibitor titer in relation to bleeding phenotype and duration of inhibitor in PPAH |
| 3. | Discuss treatment strategies and methods of inhibitor eradication in the management of PPAH | 4. | Provide appropriate counsel and education for patients and their families |
| 1. | Identify the clinical presentation and laboratory results to appropriately diagnose postpartum acquired hemophilia (PPAH) |
| 2. | Explain the significance of inhibitor titer in relation to bleeding phenotype and duration of inhibitor in PPAH |
| 3. | Discuss treatment strategies and methods of inhibitor eradication in the management of PPAH |
| 4. | Provide appropriate counsel and education for patients and their families |
Please log-in, to complete the post-test and obtain your credit.
